Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Kydog
|
31K |
15M |
4 |
21/11/23 |
21/11/23 |
Charts
|
31K
|
15M
|
4
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Kydog
|
31K |
15M |
7 |
10/11/23 |
10/11/23 |
Charts
|
31K
|
15M
|
7
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Kydog
|
31K |
15M |
3 |
09/11/23 |
09/11/23 |
Charts
|
31K
|
15M
|
3
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Kydog
|
31K |
15M |
4 |
09/11/23 |
09/11/23 |
Charts
|
31K
|
15M
|
4
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Kydog
|
31K |
15M |
9 |
09/11/23 |
09/11/23 |
Charts
|
31K
|
15M
|
9
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Kydog
|
31K |
15M |
11 |
08/11/23 |
08/11/23 |
Charts
|
31K
|
15M
|
11
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Kydog
|
31K |
15M |
11 |
07/11/23 |
07/11/23 |
Charts
|
31K
|
15M
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33 VAXINIA Study Update - Positive Early Signals
|
|
Kydog
|
315 |
144K |
30 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
315
|
144K
|
30
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Kydog
|
85 |
29K |
6 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
85
|
29K
|
6
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Kydog
|
31K |
15M |
5 |
11/10/23 |
11/10/23 |
Charts
|
31K
|
15M
|
5
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Kydog
|
31K |
15M |
10 |
21/09/23 |
21/09/23 |
Charts
|
31K
|
15M
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Licenses Allogeneic CD19 CAR T Cell Therapy
|
|
Kydog
|
479 |
207K |
14 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
479
|
207K
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Licenses Allogeneic CD19 CAR T Cell Therapy
|
|
Kydog
|
479 |
207K |
14 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
479
|
207K
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene VAXINIA Trial clears Cohort 3 of IT Monotherapy
|
|
Kydog
|
107 |
56K |
16 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
107
|
56K
|
16
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Kydog
|
31K |
15M |
1 |
27/07/23 |
27/07/23 |
Charts
|
31K
|
15M
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and RenovoRx CF33 Virotherapy Delivery Collaboration
|
|
Kydog
|
161 |
67K |
32 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
161
|
67K
|
32
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene PD1-Vaxx patent extended to 2040
|
|
Kydog
|
112 |
43K |
2 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
112
|
43K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Advances VAXINIA MAST Trial to Next IV Cohorts
|
|
Kydog
|
233 |
107K |
26 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
233
|
107K
|
26
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene doses first combination patient in PD1-Vaxx trial
|
|
Kydog
|
115 |
58K |
59 |
01/06/23 |
01/06/23 |
ASX - By Stock
|
115
|
58K
|
59
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Kydog
|
31K |
15M |
18 |
31/05/23 |
31/05/23 |
Charts
|
31K
|
15M
|
18
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA clears Imugene IND for onCARlytics first-in-class study
|
|
Kydog
|
148 |
65K |
17 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
148
|
65K
|
17
|
|
ASX - By Stock
|
IMU |
Re:
Ann: onCARlytics with ARTEMIS T cells show anti-tumour activity
|
|
Kydog
|
129 |
52K |
52 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
129
|
52K
|
52
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Kydog
|
31K |
15M |
5 |
08/05/23 |
08/05/23 |
Charts
|
31K
|
15M
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Ann: First patients dosed in IT & IV cohort 3 of VAXINIA trial
|
|
Kydog
|
89 |
51K |
34 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
89
|
51K
|
34
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene PD1-Vaxx Immunotherapy Patent Granted in the US
|
|
Kydog
|
109 |
53K |
46 |
10/02/23 |
10/02/23 |
ASX - By Stock
|
109
|
53K
|
46
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Kydog
|
31K |
15M |
11 |
25/01/23 |
25/01/23 |
Charts
|
31K
|
15M
|
11
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Kydog
|
31K |
15M |
18 |
28/12/22 |
28/12/22 |
Charts
|
31K
|
15M
|
18
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Kydog
|
31K |
15M |
2 |
19/12/22 |
19/12/22 |
Charts
|
31K
|
15M
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: First Patient Dosed in VAXINIA Intravenous Cohort 2
|
|
Kydog
|
30 |
17K |
13 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
30
|
17K
|
13
|
|
ASX - By Stock
|
IMU |
Re:
Ann: First Patient Dosed in VAXINIA Intravenous Cohort 2
|
|
Kydog
|
30 |
17K |
17 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
30
|
17K
|
17
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Kydog
|
31K |
15M |
2 |
28/10/22 |
28/10/22 |
Charts
|
31K
|
15M
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: First patient IV dosed in VAXINIA Phase 1 clinical trial
|
|
Kydog
|
59 |
35K |
15 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
59
|
35K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene doses first patient in nextHERIZON Phase 2 trial
|
|
Kydog
|
60 |
36K |
38 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
60
|
36K
|
38
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Dose Escalates in Phase I Clinical Trial of VAXINIA
|
|
Kydog
|
104 |
63K |
28 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
104
|
63K
|
28
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Kydog
|
31K |
15M |
21 |
07/07/22 |
07/07/22 |
Charts
|
31K
|
15M
|
21
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Final HER-Vaxx Phase 2 Trial Overall Survival Results
|
|
Kydog
|
439 |
227K |
19 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
439
|
227K
|
19
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Kydog
|
31K |
15M |
7 |
09/06/22 |
09/06/22 |
Charts
|
31K
|
15M
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Clarification Announcement
|
|
Kydog
|
407 |
164K |
3 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
407
|
164K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Pause in Trading
|
|
Kydog
|
164 |
82K |
3 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
164
|
82K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Termination of Supply Agreement
|
|
Kydog
|
448 |
251K |
8 |
02/05/22 |
02/05/22 |
ASX - By Stock
|
448
|
251K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Termination of Supply Agreement
|
|
Kydog
|
448 |
251K |
2 |
02/05/22 |
02/05/22 |
ASX - By Stock
|
448
|
251K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Kydog
|
99 |
62K |
5 |
22/04/22 |
22/04/22 |
ASX - By Stock
|
99
|
62K
|
5
|
|
ASX - By Stock
|
AZL |
Re:
Ann: $32.5 MILLION PLACEMENT TO FAST TRACK BIG SANDY DEVELOPMENT
|
|
Kydog
|
190 |
83K |
7 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
190
|
83K
|
7
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Kydog
|
31K |
15M |
8 |
24/03/22 |
24/03/22 |
Charts
|
31K
|
15M
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Dose Escalation in Phase 1 Clinical Trial of CHECKvacc
|
|
Kydog
|
61 |
39K |
25 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
61
|
39K
|
25
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Clinical Trial of New Cancer Oncolytic Virotherapy Vaxinia
|
|
Kydog
|
78 |
45K |
17 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
78
|
45K
|
17
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Kydog
|
31K |
15M |
21 |
01/03/22 |
01/03/22 |
Charts
|
31K
|
15M
|
21
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Half Yearly Report and Accounts
|
|
Kydog
|
60 |
34K |
5 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
60
|
34K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Half Yearly Report and Accounts
|
|
Kydog
|
60 |
34K |
4 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
60
|
34K
|
4
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Kydog
|
31K |
15M |
2 |
24/02/22 |
24/02/22 |
Charts
|
31K
|
15M
|
2
|
|